<?xml version="1.0" encoding="UTF-8"?>
<p id="Par20">Discovery studies for Zika vaccines began in 2015, followed by preclinical advances published from mid-2016. The first phase I clinical trial results were published in late 2017 [
 <xref ref-type="bibr" rid="CR6">6</xref>–
 <xref ref-type="bibr" rid="CR8">8</xref>] (see Fig. 
 <xref rid="Fig1" ref-type="fig">1</xref>), and a candidate DNA vaccine is currently in phase II clinical evaluation [
 <xref ref-type="bibr" rid="CR7">7</xref>].
</p>
